The role of immunity in protection from mucosal SIV infection in macaques

Oral Diseases

Volumn 8, Issue SUPPL. 2, 2002, Pages 63-68

  Bergmeier, L A ^a   Wang, Y ^a   Lehner, T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokine receptors; Chemokines; Innate immunity; Mucosal immunity; SIV

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN A ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; GAG PROTEIN; GAG PROTEIN P27, SIMIAN IMMUNODEFICIENCY VIRUS; GP120 PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; MACROPHAGE INFLAMMATORY PROTEIN; MEMBRANE PROTEIN; SECRETORY IMMUNOGLOBULIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; SUPPRESSOR FACTOR; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1;

ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPH NODE; MACACA; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; DISEASE MODEL; DOWN REGULATION; IMMUNIZATION; IMMUNOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; MONKEY DISEASE;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINES, CC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE PRODUCTS, GAG; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; LYMPH NODES; MACACA; MACROPHAGE INFLAMMATORY PROTEINS; MEMBRANE GLYCOPROTEINS; RECEPTORS, CCR5; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR FACTORS, IMMUNOLOGIC; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES;

EID: 18744380081     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.00014.x     Document Type: Review

References (37)

1. Ahlers JD, Dunlop N, Alling DW, Nara PL, Berzofsky JA (1997). Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytokine T lymphocytes. J Immunol 158: 3947-3958.
2. Akhatib G, Liao F, Berger EA, Peden CWC (1997). A new SIV co-receptor, STRL33. Nature 388: 238.
3. Amamori I, Zhang J, Ferguson SSG, Bieniasz PD, Cullen BR, Caron MG (1997). Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 16: 4606-4616.
4. Amara A, Le Gall S, Schwartz O et al (1997). HIV coreceptor downregulation as antiviral principle: SDF-1?-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186: 136-146.
5. Bergmeier LA, Mitchell EA, Hall G et al (1998). Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunised macaques. AIDS 12: 1139-1147.
6. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995). Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factor produced by CD8+ cells. Science 270: 1811-1815.
7. Dean M, Carrington M, Winkler C et al (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273: 1856-1862.
8. Deng H, Liu R, Ellmeier W et al (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
9. Deng H, Unutmaz D, Kewal Ramani VN, Littman DR (1997). Expression cloning of nef receptors used by simain and human immunodeficiency virus. Nature 388: 296-300.
10. Di Marzio PD, Tse J, Landau NR (1988). Chemokine receptor regolation and HIV type 1 tropism in monolyte-macrophages. AIDS Res Human Retrovirus 14: 129-138.
11. Dragic T, Litwin V, Allaway GP et al (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
12. Farzan M, Choe H, Martin K et al (1997). Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186: 405-411.
13. Feng Y, Broder CC, Kennedy PE, Berger EA (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
14. Heeney JL, Teeuwsen VJP, Van Gils M et al (1998). β-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA 95: 10803-10808.
15. Jones TC (1994). Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF). Stem Cells 12: 229-239.
16. Klavinskis LS, Brookes R, Bergmeier LA, Mitchell E, Tao L, Lehner T (1996). Mucosal or targeted lymph node immunisation of macaques with a particulate SIVp27 protein elicits virus-specific CTL in genito-rectal mucosa and draining lymph nodes. J Immunol 157: 2521-2527.
17. Lehner T, Bergmeier LA, Panagiotidi C et al (1992a). Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258: 1365-1369.
18. Lehner T, Panagiotidi C, Bergmeier LA, Tao L, Brookes R, Adams S (1992b). A comparison of the immune responses following oral, vaginal or rectal route of immunisation with SIV antigens in non-human primates. Vaccine Res 1: 319.
19. Lehner T, Brookes R, Panagiotidi C et al (1993). T and B cell functions and epitope expression in non-human primates immunised with SIV by the rectal as compared with the systemic route. Proc Natl Acad Sci USA 90: 8638-8642.
20. Lehner T, Tao L, Panagiotidi C et al (1994a). Mucosal model of genital immunisation in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol 68: 1624-1632.
21. Lehner T, Bergmeier LA, Tao L et al (1994b). Targeted lymph node immunisation with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J Immunol 153: 1858-1868.
22. Lehner T, Wang Y, Cranage M. et al (1996). Protective mucosal immunity elicited by targeted iliac lymph node immunisation with a subunit SIV envelope and core vaccine in macaques. Nat Med 2: 767-775.
23. Lehner T, Wang Y, Doyle C et al (1999a). Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. Eur J Immunol 29: 2427-2435.
24. Lehner T, Bergmeier L, Wang Y, Tao L, Mitchell E (1999b). A rational basis for mucosal vaccination against HIV infection. Immunol Rev 170: 183-196.
25. Lehner T, Wang Y, Cranage MC et al (2000). Upregulation of β chemokines, downmodulation of CCR5 coreceptors and inhibition of SIV transmission in vivo. Immunology 99 (4): 569-577.
26. Liao F, Alkhatib G, Peden KW, Sharma G, Benger EA, Farber JM (1997). STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophages-tropic and T cell line tropic HIV-1. J Exp Med 11: 2015-2023.
27. Liu R, Paxton WA, Choe S et al (1996). Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV infection. Cell 86: 367-377.
28. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Hum Retro 8: 629-640.
29. Mitchell EA, Bergmeier LA, Doyle C et al (1998). Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur J Immunol 28: 3066-3074.
30. Moss RB, Wallace MR, Lanza P et al (1998). In vitro p24 antigen-stimulated lymphocyte proliferation and β-chemokine production in human immuno-deficiency virus type 1 (HIV-1)-seropositive subjects after immunisation with an in-activated gp120-depleted HIV-1 immunogen (remune). Clin Diag Laboratory 5: 308-312.
31. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature (Lond) 382: 722-725.
32. UNAIDS (2000). AIDS Epidemic update: June 2000. WHO: Geneva.
33. Vogel FR (1995). The role of adjuvants in retroviral vaccines. Int J Immunopharmac 17: 85-90.
34. Walker CM, Moody DJ, Stiles DP, Levy JA (1986). CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563-1566.
35. Wang Y, Tao L, Mitchell E et al (1998). Generation of CD8-SF and β-chemokines, induced by xenogeneic immunisation, in the prevention of SIV infection in macaques. Proc Natl Acad Sci USA 95: 5223-5228.
36. Wang Y, Tao L, Mitchell E et al (1999a). Allo-immunisation elicitis CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med 5: 1004-1009.
37. Wang Y, Tao L, Mitchell E, Bergmeier L, Doyle C, Lehner T (1999b). The effect of immunisation on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis. Vaccine 17: 1826-1836.